Correlation Between Singular Genomics and Nexalin Technology
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and Nexalin Technology, you can compare the effects of market volatilities on Singular Genomics and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Nexalin Technology.
Diversification Opportunities for Singular Genomics and Nexalin Technology
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Singular and Nexalin is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Singular Genomics i.e., Singular Genomics and Nexalin Technology go up and down completely randomly.
Pair Corralation between Singular Genomics and Nexalin Technology
Given the investment horizon of 90 days Singular Genomics is expected to generate 4.58 times less return on investment than Nexalin Technology. But when comparing it to its historical volatility, Singular Genomics Systems is 1.53 times less risky than Nexalin Technology. It trades about 0.03 of its potential returns per unit of risk. Nexalin Technology is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 93.00 in Nexalin Technology on August 28, 2024 and sell it today you would earn a total of 297.00 from holding Nexalin Technology or generate 319.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Singular Genomics Systems vs. Nexalin Technology
Performance |
| Timeline |
| Singular Genomics Systems |
| Nexalin Technology |
Singular Genomics and Nexalin Technology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Singular Genomics and Nexalin Technology
The main advantage of trading using opposite Singular Genomics and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.| Singular Genomics vs. Nutex Health | Singular Genomics vs. Mangoceuticals, Common Stock | Singular Genomics vs. Aclarion |
| Nexalin Technology vs. Electromed | Nexalin Technology vs. Armm Inc | Nexalin Technology vs. SurModics | Nexalin Technology vs. Bluejay Diagnostics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |